Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,586,623
-
Total 13F shares
-
1,926,605
-
Share change
-
+119,076
-
Total reported value
-
$1,791,233
-
Price per share
-
$0.93
-
Number of holders
-
16
-
Value change
-
+$109,351
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q3 2022
As of 30 Sep 2022,
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,926,605 shares.
The largest 10 holders included
COMMONWEALTH EQUITY SERVICES, LLC, VANGUARD GROUP INC, Roumell Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, EP Wealth Advisors, LLC, STATE STREET CORP, NORTHERN TRUST CORP, GROUP ONE TRADING, L.P., and BlackRock Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.